These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 13181491)

  • 1. [Epidemiology of Mediterranean human visceral leishmaniasis with special reference to its relation to canine leishmaniasis].
    GIRAUD P; RANQUE J; CABASSU H
    Arch Fr Pediatr; 1954; 11(4):337-53. PubMed ID: 13181491
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mediterranean leishmaniasis caused by Leishmania infantum. Update on the utility of the IT-Leish and ID-Pagia leishmaniasis tests].
    Marty P; Delaunay P; Fissore C; Le Fichoux Y
    Med Trop (Mars); 2007 Feb; 67(1):79-85. PubMed ID: 17506280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterologous prime-boost vaccination with a non-replicative vaccinia recombinant vector expressing LACK confers protection against canine visceral leishmaniasis with a predominant Th1-specific immune response.
    Ramos I; Alonso A; Marcen JM; Peris A; Castillo JA; Colmenares M; Larraga V
    Vaccine; 2008 Jan; 26(3):333-44. PubMed ID: 18093705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Canine leishmaniasis in Campania: new and old foci].
    Baldi L; Mizzoni V; Guarino A
    Parassitologia; 2004 Jun; 46(1-2):217-20. PubMed ID: 15305720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunology of canine leishmaniasis.
    Barbiéri CL
    Parasite Immunol; 2006 Jul; 28(7):329-37. PubMed ID: 16842269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology and direct medical costs of human leishmaniasis in Italy.
    Mannocci A; La Torre G; Chiaradia G; De Waure C; Mainelli MT; Cernigliaro A; Bruno S; Ricciardi W
    J Prev Med Hyg; 2007 Mar; 48(1):27-36. PubMed ID: 17506235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leishmaniasis in Turkey: molecular characterization of Leishmania from human and canine clinical samples.
    Toz SO; Nasereddin A; Ozbel Y; Ertabaklar H; Culha G; Sevil N; Ziya Alkan M; Jaffe CL
    Trop Med Int Health; 2009 Nov; 14(11):1401-6. PubMed ID: 19737374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canine leishmaniasis.
    Alvar J; Cañavate C; Molina R; Moreno J; Nieto J
    Adv Parasitol; 2004; 57():1-88. PubMed ID: 15504537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Epidemiology of human Mediterranean visceral leishmaniasis, particularly in its relations with canine leishmaniasis].
    GIRAUD P; RANQUE J; CABASSU H
    Pathol Gen; 1950 Apr; 50(617):282-305. PubMed ID: 15417943
    [No Abstract]   [Full Text] [Related]  

  • 10. [Interpretation of laboratory data during cryptic leishmaniasis in dog].
    Gravino AE
    Parassitologia; 2004 Jun; 46(1-2):227-9. PubMed ID: 15305723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
    Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
    Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sero-epidemological survey on canine visceral leishmaniasis and the distribution of sandfly vectors in northwestern Turkey: prevention strategies for childhood visceral leishmaniasis.
    Dogan N; Ozbel Y; Toz SO; Dinleyici EC; Bor O
    J Trop Pediatr; 2006 Jun; 52(3):212-7. PubMed ID: 16287909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decrease of the incidence of human and canine visceral leishmaniasis after dog vaccination with Leishmune in Brazilian endemic areas.
    Palatnik-de-Sousa CB; Silva-Antunes I; Morgado Ade A; Menz I; Palatnik M; Lavor C
    Vaccine; 2009 Jun; 27(27):3505-12. PubMed ID: 19464528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The direct agglutination test as an alternative method for the diagnosis of canine and human visceral leishmaniasis.
    Terán-Angel G; Schallig H; Zerpa O; Rodríguez V; Ulrich M; Cabrera M
    Biomedica; 2007 Sep; 27(3):447-53. PubMed ID: 18320110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Participation of Rhipicephalus sanguineus (Acari: Ixodidae) in the epidemiology of canine visceral leishmaniasis.
    Coutinho MT; Bueno LL; Sterzik A; Fujiwara RT; Botelho JR; De Maria M; Genaro O; Linardi PM
    Vet Parasitol; 2005 Mar; 128(1-2):149-55. PubMed ID: 15725545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of serologic tests for the diagnosis of asymptomatic visceral leishmaniasis in an endemic area.
    Romero HD; Silva Lde A; Silva-Vergara ML; Rodrigues V; Costa RT; Guimarães SF; Alecrim W; Moraes-Souza H; Prata A
    Am J Trop Med Hyg; 2009 Jul; 81(1):27-33. PubMed ID: 19556562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leishmaniases in the Mediterranean in the era of molecular epidemiology.
    Schönian G; Mauricio I; Gramiccia M; Cañavate C; Boelaert M; Dujardin JC
    Trends Parasitol; 2008 Mar; 24(3):135-42. PubMed ID: 18262469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of canine visceral leishmaniasis: biotechnological advances.
    Gomes YM; Paiva Cavalcanti M; Lira RA; Abath FG; Alves LC
    Vet J; 2008 Jan; 175(1):45-52. PubMed ID: 17150389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visceral leishmaniasis (kala-azar) and pregnancy.
    Figueiró-Filho EA; Duarte G; El-Beitune P; Quintana SM; Maia TL
    Infect Dis Obstet Gynecol; 2004; 12(1):31-40. PubMed ID: 15460194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human and canine leishmaniasis in asymptomatic and symptomatic population in Northwestern Greece.
    Papadopoulou C; Kostoula A; Dimitriou D; Panagiou A; Bobojianni C; Antoniades G
    J Infect; 2005 Jan; 50(1):53-60. PubMed ID: 15603841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.